Genetic Reprogramming
Changing what a cell does by editing or adjusting its genes, rather than replacing the cell. Tools such as CRISPR are packed into a harmless virus shell or a fatty bubble and delivered to the target cells, where they change the DNA at an exact spot. One line of research briefly winds back a cell's age, and has restored youthful function in animal tissue. Caution is on the record: the same mechanism sits close to how cancers start.
Readiness
Not scored. Watchlist entries do not enter any gradient. WKO Innovation Map 26/27 (2026)
Techniques that change gene expression or cellular identity - CRISPR editing, mRNA reprogramming, epigenetic modulation - altering what a cell does rather than replacing it.
The partial-reprogramming work is the reason this category attracts attention. Applying a subset of the factors that revert an adult cell to a stem-like state, briefly and reversibly, has restored youthful function in animal tissue without erasing cell identity, and it is one of the few interventions in ageing biology with a plausible mechanism rather than a correlation.
Scores of 4 and 3.5 are appropriately cautious, and the reason is on the record: the same mechanism that resets a cell's age is adjacent to the mechanism that makes a cell cancerous. Controlling the dose and the duration is not a detail. It is the whole safety question.
Common misconception: that reprogramming and gene editing are the same thing. Editing changes the sequence permanently. Reprogramming changes which genes are expressed, and the distinction matters for both what it can do and what it risks.
Possibly related megatrends - unreviewed
Unreviewed. Derived from this technology's WKO cluster, not from a judgement about this technology. A starting point for review, not a claim.
Talin, B. (2026). Genetic Reprogramming. The Future Explorer, dataset v0.4.0 (2026-11-16). https://explorer.talin.digital/e/genetic-reprogramming/